Related Experiment Video
Updated: Jul 16, 2026

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis (ALS)
Published on: March 17, 2012
Dysequilibrium between caspases and their inhibitors in a mouse model for amyotrophic lateral sclerosis
Eiichi Tokuda1, Shin-ichi Ono, Kumiko Ishige
1Research Unit of Clinical Pharmacy, College of Pharmacy, Nihon University, 7-7-1, Narashinodai, Funabashi, Chiba, 274-8555, Japan.
Abstract:
Mutations in copper/zinc superoxide dismutase (SOD1) have been implicated in the pathogenesis of familial amyotrophic lateral sclerosis (ALS). Mutant SOD1 protein likely gains a novel cytotoxic property, leading to the death of motor neurons. We therefore investigated whether caspase-mediated apoptosis is associated with novel cytotoxic properties in a rodent model for familial ALS (G93A SOD1 transgenic mice). Caspase-9 (an effecter in the mitochondrial apoptotic pathway), caspase-8 (an effecter in the Fas apoptotic pathway), and caspase-3 (an executioner of both pathways) proteins were all present in nonactive forms in the spinal cords of wild-type mice during the early stage of the disease (8 weeks), at which time the mice had not yet exhibited motor paralysis. In transgenic mice, however, these proteins were present in their active forms, and their mRNA levels were significantly upregulated in the represent to this conversion from nonactive to active forms. During the advanced stage of the disease (16 weeks), when paralysis was evident, the active caspase levels were further elevated. On the other hand, the mRNA and protein levels of survivin, a counteraction protein against caspases, were significantly suppressed during the early stage, and sharply increased during the advanced stage. Although the mRNA and protein levels of X-linked inhibitor of apoptosis protein (XIAP) remained at the same levels as those seen in the control (wild-type mice) during the early stage, they were significantly depressed at an age of 16 weeks. These findings were observed exclusively in the spinal cord, the region responsible for the disease, and not in the cerebellum, a non-responsible region. We conclude that conditions facilitating the apoptotic process during the early stage of the disease play causative roles in the pathogenesis of ALS and that the suppression of XIAP levels during the advanced stage could contribute to disease expression and/or progression.
Insights
Mutations in copper/zinc superoxide dismutase (SOD1) trigger apoptosis in familial amyotrophic lateral sclerosis (ALS). Active caspases and suppressed apoptosis inhibitors in the spinal cord indicate early disease involvement and progression.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Familial amyotrophic lateral sclerosis (ALS) is linked to mutations in copper/zinc superoxide dismutase (SOD1).
- Mutant SOD1 may acquire new toxic properties, causing motor neuron death.
- Investigating caspase-mediated apoptosis in a rodent model of familial ALS is crucial.
Purpose of the Study:
- To determine if caspase-mediated apoptosis is associated with the novel cytotoxic properties of mutant SOD1.
- To analyze the activation of key caspases (caspase-9, -8, -3) and apoptosis-regulating proteins (survivin, XIAP) in the spinal cords of G93A SOD1 transgenic mice.
Main Methods:
- Utilized a G93A SOD1 transgenic mouse model for familial ALS.
- Analyzed caspase-9, -8, and -3 protein activity and mRNA levels at early (8 weeks) and advanced (16 weeks) disease stages.
- Assessed mRNA and protein levels of survivin and X-linked inhibitor of apoptosis protein (XIAP).
- Compared findings in the spinal cord (disease-affected) versus the cerebellum (unaffected).
Main Results:
- Active caspase-9, -8, and -3 proteins and upregulated mRNA were found in transgenic mice at 8 weeks, preceding paralysis.
- Active caspase levels further increased by 16 weeks when paralysis was evident.
- Survivin levels were suppressed early and increased late, while XIAP levels decreased significantly at 16 weeks.
- These changes were specific to the spinal cord, not the cerebellum.
Conclusions:
- Apoptotic processes activated early in the disease play a causal role in ALS pathogenesis.
- Suppression of XIAP during the advanced stage may contribute to ALS disease expression and progression.
- Targeting caspase activation and modulating apoptosis inhibitors could be potential therapeutic strategies for ALS.
More Related Videos
10:45Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depolarization
Published on: January 13, 2012
08:59Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021